Trump Said to Discuss Veterans’ Care Overhaul With Hospital CEOs
By Zachary Tracer, Shannon Pettypiece and Jennifer Epstein – December 28, 2016
President-elect Donald Trump met at his Florida resort on Wednesday with leaders of top U.S. nonprofit hospital systems to discuss overhauling health care for veterans, including by allowing them to more readily visit hospitals outside the Veterans Affairs system.
The group weighed public-private partnerships and other options that would make it possible for veterans to go to any hospital for care, inside the VA system or outside of it, a senior transition official said after the meeting. Some veterans advocacy groups have cautioned against expanding access to care outside the government-run hospitals under the Veterans Health Administration, fearing the system may be weakened by privatization.
The VA system spends about $70 billion a year on medical care, offering a potential windfall to private hospitals if more veterans are allowed into their beds.
John Noseworthy, chief executive officer of the Mayo Clinic; Paul Rothman, CEO of Johns Hopkins Medicine; David Torchiana, CEO of Partners HealthCare; and Toby Cosgrove, CEO of the Cleveland Clinic, whom Trump interviewed for VA secretary, traveled to Palm Beach for the meeting. A restructuring consultant, Marc Sherman of the firm Alvarez & Marsal, also participated, according to the transition official, who described the meeting on condition of anonymity.
A person close to Marvel Entertainment CEO Ike Perlmutter said he also participated in a meeting with Trump and the health-care executives. Perlmutter has contributed $50 million to New York University Langone Medical Center, where the cancer center is named for him and his wife.
‘Health Outcomes’
The hospital executives left the meeting without speaking to reporters, and their institutions provided little detail. Rothman, in a message to Johns Hopkins staff obtained by Bloomberg, said the meeting with Trump “reflects his recognition of the critical importance of health care and biomedical research to the country.”